Hansoh Pharmaceutical Group Company Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
6/10
|
23.28 | 35.42 | -34.26% | 48.9 | -52.39% |
| P/S |
|
7.55 | 7.59 | -0.4689% |
|
|
| P/BV |
|
2.96 | 3.68 | -19.72% |
|
|
| P/FCF |
|
22.11 | 55.38 | -60.08% |
|
|
| Ev/Ebitda |
|
25.04 | 2.91 | 761.01% |
|
|
| Ev/S |
|
8.3 | 23.72 | -64.99% |
|
|
| Ev/FCF |
|
30.47 | 63.78 | -52.24% |
|
|
| E/P |
|
0.0538 | 0.0326 | 64.95% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
33.16 | -13.64 | -343.03% | 34.54 | -4.01% |
| ROE |
|
13.53 | 5.19 | 160.9% |
|
|
| ROA |
|
10.4 | 3.47 | 199.69% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
32.44 | -11.49 | -382.41% |
|
|
| ROCE |
|
0 | 0.2627 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
8/10
|
1.31 | 0.7755 | 68.6% | 0.7912 | +65.26% |
| Nеt Debt/Ebitda |
|
0.4826 | 0.0127 | 3685.89% |
|
|
| Debt/Ratio |
|
0.1326 | 0.1229 | 7.91% |
|
|
| Debt/Equity |
|
1.26 | 0.8005 | 57.24% |
|
|
| Debt/Net Income |
|
1.34 | 1.76 | -23.96% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
5.05/10
|
2.02 | 5.7 | -64.56% | 1.53 | +31.61% |
| Number of years of dividend growth |
|
3 | 1.13 | 166.67% | ||
| DSI |
|
1 | 0.5838 | 71.29% |
|
|
| Average dividend growth |
|
38.67 | 3.2 | 1107.37% |
|
|
| Average percentage for 5 years |
|
1.53 | 4.95 | -69.01% |
|
|
| Average percentage for payments |
|
68.53 | 23.96 | 186.03% |
|
|
| Difference from average difference in sector |
|
-3.68 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
3/10
|
16.37 | 21.26 | -23% | ||
| Growth impulse Ebitda in 5 years |
|
45.16 | -43.94 | -202.78% | ||
| Growth impulse Net Income in 5 years |
|
28.19 | 83.64 | -66.3% | ||
| Growth impulse FCF in 5 years |
|
0.7885 | 79.76 | -99.01% | ||
| Growth impulse EPS in 5 years |
|
1074.7 | -117.1 | -1017.76% |
IP Score
5.97/10
